Volver a Agenda
Session Chair(s)
Cindy Luxhoj Hahn
Founder and CEO
Alagille Syndrome Alliance, United States
Learning Objective : Discuss the value of NCATS' program in spurring the drug development process; Describe challenges inherent in drug rescue and repurposing; Identify the innovative partnering opportunities and potential for accelerated therapeutic discoveries presented by this strategy.
Speaker(s)
A Case Study
Ciara Kennedy, PHD, MBA, MSC
Lumena Pharmaceuticals, United States
Vice President, Operations
Regulatory Challenges of Rescue and Repurposing
Larissa Lapteva
FDA, United States
Associate Director, Division of Clinical Evaluation, OTAT, CBER
Catalyzing Innovation at the National Center for Advancing Translational Sciences
John C. McKew, PHD
National Center for Advancing Translational Sciences (NCATS), United States
Acting Scientific Director, Division of Preclinical Innovation TRND, BrIDGs
¿Tiene una cuenta?